Loading: 100%
Zimmer Biomet Holdings logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter Warsaw, United States of AmericaWarsaw, United States of Americano data available
Employees 18,500 (as per Q3 2016)no data available
Sector Medical Devices, HealthcareMedical Devices, Healthcareno data available
Ticker ZBHno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 1795105115125135
datesClosing price (adj.)
13.10.2017119.70
11.10.2017118.64
04.10.2017117.53
27.09.2017116.25
20.09.2017115.97
13.09.2017115.64
06.09.2017115.39
30.08.2017112.77
23.08.2017112.04
16.08.2017112.84
09.08.2017112.62
02.08.2017117.44
26.07.2017128.43
19.07.2017130.79
12.07.2017126.09
05.07.2017127.50
27.06.2017127.98
20.06.2017126.71
13.06.2017124.97
06.06.2017123.68
30.05.2017117.96
23.05.2017117.34
16.05.2017119.30
09.05.2017118.19
02.05.2017120.15
25.04.2017124.01
18.04.2017119.09
11.04.2017119.10
04.04.2017120.29
28.03.2017120.47
21.03.2017120.26
14.03.2017117.97
07.03.2017116.37
28.02.2017116.38
21.02.2017116.47
14.02.2017116.48
07.02.2017117.41
31.01.2017117.63
24.01.2017113.88
17.01.2017114.76
10.01.2017112.99
03.01.2017102.72
27.12.2016102.29
19.12.2016102.01
12.12.2016104.94
05.12.2016100.59
28.11.2016101.14
21.11.2016101.25
14.11.201697.18
07.11.2016103.59
31.10.2016104.53
24.10.2016126.93
17.10.2016125.57
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
119.70n/a
Market Capitalisation
in million USD
23,976n/a
Enterprise Value
in million USD
35,070n/a
Common Shares Outstanding
as per Oct 28, 2016
200,299,566n/a
Preferred Shares Outstanding
as per Oct 28, 2016
n/a
Average Basic Shares Outstanding
TTM
200,700,000n/a
Average Diluted Shares Outstanding
TTM
203,625,000n/a
Index Membership
n/a
Business Summary
Zimmer Biomet Holdings Inc is a medical device company. It designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery under brands like NexGen, VerSys, SoPlus, and Pulsavac.
no data available
Key Financials & Ratios (all figures TTM as per Sep 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 7,604n/a
Gross Profit 5,175n/a
Operating Income 1,333n/a
EBITDA 2,405n/a
Net Profit 363n/a
Balance Sheet
Cash and Cash Equivalents 489n/a
Receivables 1,604n/a
Total Current Assets 4,698n/a
PP&E 2,081n/a
Total Assets 27,037n/a
Accounts Payable 266n/a
Current Debt 576n/a
Total Current Liabilities 2,312n/a
Long-Term Debt 11,006n/a
Total Liabilities 17,290n/a
Total Equity 9,746n/a
Cash Flow
Depreciation & Amortisation 1,072n/a
Change in Working Capital -347n/a
Operating Cash Flow 1,434n/a
Net Change in PP&E and Intangibles -133n/a
Investing Cash Flow -8,215n/a
Dividends Paid -185n/a
Financing Cash Flow -939n/a
Total Change in Cash -7,731n/a
Free Cash Flow 1,784n/a
Profitability Ratios
Gross Margin 68.1%n/a
Operating Margin 17.5%n/a
Net Profit Margin 4.8%n/a
Return on Equity 3.7%n/a
Return on Assets 1.3%n/a
Per Share Figures
Basic EPS 1.81n/a
Diluted EPS 1.78n/a
Sales per Share 37.89n/a
Book Value per Share 48.56n/a
FCF per Share 8.89n/a
Dividends per Share 0.92n/a
Price Multiples
Price to Earnings Ratio 66.13n/a
Price to Sales Ratio 3.16n/a
Price to Book Value 2.46n/a
Price to Free Cash Flow 13.47n/a
Valuation Metrics
EV/EBITDA 14.58n/a
EV/Sales 4.61n/a
Book to Market Value 0.41n/a
Other Ratios
Current Ratio 203.2%n/a
Liabilities to Equity Ratio 177.4%n/a
Debt to Assets Ratio 42.8%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Revenue
3,898
4,121
4,095
4,220
4,452
4,472
4,623
4,673
5,998
Sales & Services Revenue
0
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
0
Cost of revenue
-876
-997
-991
-1,012
-1,122
-1,125
-1,267
-1,243
-1,801
Cost of Goods & Services
0
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
0
Gross Profit
3,022
3,124
3,105
3,208
3,330
3,347
3,357
3,431
4,197
Other Operating Income
0
0
0
0
0
0
0
0
0
Operating Expenses
-1,699
-1,896
-1,935
-1,978
-2,073
-2,033
-2,031
-2,031
-2,890
Selling, General & Administrative
-1,517
-1,704
-1,729
-1,759
-1,834
-1,807
-1,749
-1,751
-2,284
Selling & Marketing
0
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
0
Research & Development
-183
-192
-206
-219
-238
-226
-203
-187
-269
Depreciation & Amortization
0
0
0
0
0
0
-79
-93
-337
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
0
Operating Income (Loss)
1,322
1,228
1,170
1,230
1,257
1,314
1,326
1,400
1,307
Non-Operating Income (Loss)
4
32
-21
-57
-45
-57
-61
-98
-314
Interest Expense, net
4
32
-21
-57
-45
-57
-55
-51
-277
Interest Expense
0
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
0
0
-6
-47
-37
Pretax Income (Loss), Adjusted
1,326
1,259
1,149
1,174
1,212
1,257
1,265
1,302
993
Abnormal Gains (Losses)
-195
-138
-151
-314
-233
-266
-257
-363
-840
Acquired In-Process R&D
0
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
0
Pretax Income (Loss)
1,132
1,122
998
860
979
990
1,008
939
153
Income Tax (Expense) Benefit, net
-358
-272
-281
-263
-219
-237
-230
-220
-7
Current Income Tax
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
774
850
717
597
760
753
779
719
146
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
774
850
717
597
760
753
779
719
146
Minority Interest
-1
-1
0
0
1
2
2
1
1
Net Income
773
849
717
597
761
755
780
720
147
Preferred Dividends
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
773
849
717
597
761
755
780
720
147
Remarks
restated on Feb 25, 2010 n/a
calculated values,
restated on Feb 25, 2011 n/a
calculated values,
restated on Feb 27, 2012 n/a
calculated values,
restated on Feb 27, 2013 n/a
calculated values,
restated on Feb 28, 2014 n/a
calculated values,
restated on Feb 23, 2015 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
Balance SheetBS data quality: 94% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
213
758
934
1,224
1,556
1,808
1,696
1,624
Cash & Cash Equivalents
n/a
213
692
669
768
884
1,081
1,083
1,459
Short Term Investments
n/a
0
66
265
456
672
727
613
165
Accounts & Notes Receivable
n/a
733
751
776
839
885
937
912
1,447
Accounts Receivable, Net
n/a
733
751
776
839
885
937
912
1,447
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
0
Inventories
n/a
928
913
936
930
995
1,075
1,193
2,254
Raw Materials
n/a
0
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
0
Other Short Term Assets
n/a
305
315
363
284
273
379
512
529
Prepaid Expenses
n/a
104
105
128
74
76
107
317
529
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
198
210
236
211
197
272
195
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
3
0
0
0
0
0
0
0
Total Current Assets
n/a
2,179
2,738
3,010
3,277
3,709
4,198
4,313
5,854
Property, Plant & Equipment, Net
n/a
1,264
1,222
1,214
1,207
1,211
1,225
1,285
2,063
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
0
Other Long Term Assets
n/a
3,796
3,826
3,776
4,031
4,093
4,158
4,059
19,244
Intangible Assets
n/a
872
858
827
799
741
708
604
8,746
Goodwill
n/a
2,775
2,784
2,581
2,626
2,572
2,611
2,514
9,934
Other Intangible Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
149
184
369
607
781
839
942
564
Total Noncurrent Assets
n/a
5,060
5,048
4,990
5,239
5,304
5,383
5,345
21,307
Total Assets
n/a
7,239
7,786
8,000
8,515
9,012
9,581
9,658
27,161
Liabilities and owners' equity
Payables & Accruals
n/a
213 213000000
192 192100000
179 178500000
152 151900000
207 206900000
368 367500000
226 225500000
432 432000000
Accounts Payable
n/a
186 186400000
135 134600000
130 129600000
143 143300000
184 184100000
146 146300000
145 145200000
285 284800000
Accrued Taxes
n/a
27 26600000
58 57500000
49 48900000
9 8600000
23 22800000
221 221200000
80 80300000
147 147200000
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Debt
n/a
0 0
0 0
0 0
143 143300000
100 100100000
0 0
0 0
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
558 558100000
499 498600000
524 524000000
572 571900000
559 559000000
664 664100000
799 798500000
1,186 1185900000
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
558 558100000
499 498600000
524 524000000
572 571900000
559 559000000
664 664100000
799 798500000
1,186 1185900000
Total Current Liabilities
n/a
771 771100000
691 690700000
703 702500000
867 867100000
866 866000000
1,032 1031600000
1,024 1024000000
1,618 1617900000
Long Term Debt
n/a
460 460100000
1,128 1127600000
1,142 1142100000
1,576 1576000000
1,721 1720800000
1,672 1672300000
1,426 1425500000
11,497 11497400000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
354 353900000
329 328500000
384 384000000
557 557400000
559 559300000
577 576600000
657 656800000
4,156 4155900000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
46 45900000
3,150 3150200000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
354 353900000
329 328500000
384 384000000
557 557400000
559 559300000
577 576600000
611 610900000
1,006 1005700000
Total Noncurrent Liabilities
n/a
814 814000000
1,456 1456100000
1,526 1526100000
2,133 2133400000
2,280 2280100000
2,249 2248900000
2,082 2082300000
15,653 15653300000
Total Liabilities
n/a
1,585 1585100000
2,147 2146800000
2,229 2228600000
3,001 3000500000
3,146 3146100000
3,281 3280500000
3,106 3106300000
17,271 17271200000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
3,141 3141000000
3,217 3217100000
3,296 3296000000
3,402 3401700000
3,503 3503200000
4,003 4003200000
4,333 4333400000
8,198 8198300000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
-2,116 -2116200000
-3,040 -3039500000
-3,545 -3545100000
-4,593 -4592700000
-5,072 -5072100000
-5,786 -5785700000
-6,184 -6183700000
-6,329 -6329100000
Retained Earnings
n/a
4,386 4385500000
5,103 5102500000
5,699 5699400000
6,427 6426800000
7,086 7085900000
7,713 7712700000
8,362 8362100000
8,348 8347700000
Other Equity
n/a
240 240000000
359 358600000
321 321000000
271 271400000
344 343900000
367 367100000
38 38100000
-329 -329000000
Equity Before Minority Interest
n/a
5,650 5650300000
5,639 5638700000
5,771 5771300000
5,507 5507200000
5,861 5860900000
6,297 6297300000
6,550 6549900000
9,888 9887900000
Minority Interest
n/a
4 3600000
0 0
0 0
8 7600000
5 5400000
3 2800000
2 1800000
2 1500000
Total Equity
n/a
5,654 5653900000
5,639 5638700000
5,771 5771300000
5,515 5514800000
5,866 5866300000
6,300 6300100000
6,552 6551700000
9,889 9889400000
Total Liabilities & Equity
n/a
7,239 7239000000
7,786 7785500000
8,000 7999900000
8,515 8515300000
9,012 9012400000
9,581 9580600000
9,658 9658000000
27,161 27160600000
Remarks restated on n/a restated on Feb 25, 2010 n/a restated on Feb 25, 2011 n/a restated on Feb 27, 2012 n/a restated on Feb 27, 2013 n/a restated on Feb 28, 2014 n/a restated on Feb 23, 2015 n/a restated on Feb 29, 2016 n/a restated on Nov 8, 2016 n/a
Cash Flow StatementCF data quality: 94% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Net Income/Starting Line
773
849
717
597
760
753
779
719
146
Net Income
0
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
230
275
337
340
360
363
359
376
712
Non-Cash Items
155
85
112
198
60
99
-40
-10
341
Stock-Based Compensation
0
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
0
Change in Working Capital
-74
-170
-49
59
-3
-63
-134
-33
-383
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
0
Cash from Operating Activities
1,084
1,038
1,118
1,194
1,177
1,152
963
1,053
817
Change in Fixed Assets & Intangibles
-331
-597
-265
-280
-269
-264
-293
-342
-364
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
0
55
-66
-346
-267
-252
98
-69
588
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
-382
-40
-83
-57
-59
-74
-54
-7,760
Net Cash from Divestitures
0
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
0
Other Investing Activities
-160
0
-11
-18
-31
-18
-14
-4
-22
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
-492
-924
-381
-727
-624
-592
-283
-469
-7,558
Dividends Paid
0
0
0
0
0
-94
-132
-146
-157
Cash From (Repayment of) Debt
0
330
669
-2
550
97
-98
-248
7,388
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
-427
-680
-914
-489
-1,007
-439
-246
-116
-45
Increase in Capital Stock
0
0
0
0
0
0
0
0
0
Decrease in Capital Stock
0
0
0
0
0
0
0
0
0
Other Financing Activities
27
7
-17
1
1
-1
9
-53
-47
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
-400
-344
-262
-490
-456
-437
-467
-562
7,140
Net Cash Before Disc. Operations and FX
193
-230
474
-23
97
123
213
21
399
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
0
Net Cash Before FX
193
-230
474
-23
97
123
213
21
399
Effect of Foreign Exchange Rates
5
-22
5
0
3
-7
-17
-18
-23
Net Changes in Cash
198
-251
479
-23
99
116
196
3
376
Remarks
restated on Feb 25, 2010 n/a
calculated values,
restated on Feb 25, 2011 n/a
calculated values,
restated on Feb 27, 2012 n/a
calculated values,
restated on Feb 27, 2013 n/a
calculated values,
restated on Feb 28, 2014 n/a
calculated values,
restated on Feb 23, 2015 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo